Anti-Cytokeratin 10 antibody [LH2] (ab20208)

Overview

• Product nameAnti-Cytokeratin 10 antibody [LH2]See all Cytokeratin 10 primary antibodies ...
• Description
  Mouse monoclonal [LH2] to Cytokeratin 10
• Tested applicationsIHC-P, IHC-Fr more details
• Species reactivity
  Reacts with: Human
  
• Immunogen

  Extract of skin from psoriasis patient (Human).

Properties

• FormLiquid
• Storage instructionsStore at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
• Storage bufferPreservative: None
  Constituents: PBS
• Concentration information loading...
• PurityProtein G purified
• Clonality Monoclonal
• Clone numberLH2
• MyelomaSp2
• IsotypeIgG1
• Research Areas
  • Signal Transduction
  • Cytoskeleton / ECM
  • Cytoskeleton
  • Intermediate Filaments
  • Class I
  • Cytokeratins

Applications

Target

• Tissue specificitySeen in all suprabasal cell layers including stratum corneum.
• Involvement in diseaseDefects in KRT10 are a cause of bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800]; also known as epidermolytic hyperkeratosis (EHK) or bullous erythroderma ichthyosiformis congenita of Brocq. BCIE is an autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop.
  Defects in KRT10 are a cause of ichthyosis annular epidermolytic (AEI) [MIM:607602]; also known as cyclic ichthyosis with epidermolytic hyperkeratosis. AEI is a skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale, which coalesce to involve most of the body surface and can persist for several weeks or even months.
• Sequence similaritiesBelongs to the intermediate filament family.

Target information above from: UniProt accession P13645 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) .

Information by UniProt
• Database links
  • Entrez Gene: 3858 Human
  • Omim: 148080 Human
  • SwissProt: P13645 Human
  • Unigene: 99936 Human

• Alternative names
  BCIE antibodyBIE antibodyCK 10 antibody

  CK-10 antibodyck10 antibodyCytokeratin 10 antibodyCytokeratin-10 antibodyCytokeratin10 antibodyEHK antibodyk10 antibodyK1C10_HUMAN antibodyKeratin 10 antibodyKeratin antibodyKeratin type i cytoskeletal 10 antibodyKeratin type I cytoskeletal 59 kDa antibodyKeratin-10 antibodyKeratin10 antibodykpp antibodyKrt 10 antibodyKRT10 antibodykrt10  antibodytype I cytoskeletal 10 antibody

  see all

Anti-Cytokeratin 10 antibody [LH2] images

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 10 antibody [LH2] (ab20208)
  Ab20208 staining Human normal skin. Staining is localised to cytoplasmic compartment.
  Left panel: with primary antibody at 1 ug/ml. Right panel: isotype control.
  Sections were stained using an automated system DAKO Autostainer Plus , at room temperature: sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.